"10.1371_journal.pone.0039036","plos one","2012-06-20T00:00:00Z","Sachiko Ohshima-Hosoyama; Heather A Simmons; Nichole Goecks; Valerie Joers; Christine R Swanson; Viktoriya Bondarenko; Rebecca Velotta; Kevin Brunner; Laura D Wood; Ralph H Hruban; Marina E Emborg","Preclinical Parkinsons Research Program, Wisconsin National Primate Research Center, University of Wisconsin–Madison, Madison, Wisconsin, United States of America; Wisconsin National Primate Research Center, University of Wisconsin–Madison, Madison, Wisconsin, United States of America; Neuroscience Training Program, University of Wisconsin–Madison, Madison, Wisconsin, United States of America; Department of Medical Physics, University of Wisconsin–Madison, Madison, Wisconsin, United States of America; Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America","Conceived and designed the experiments: MEE. Performed the experiments: CRS KB MEE NG RV SOH VB VJ. Analyzed the data: HAS LDW MEE RH SOH. Contributed reagents/materials/analysis tools: MEE. Wrote the paper: SOH HAS MEE. Manuscript writing critical review: CRS HAS KB LDW MEE NG RH RV SOH VB VJ.","HIRmAb-GDNF (AGT-190) was provided by ArmaGen Technologies for this study. The Michael J. Fox Foundation awarded to ArmaGen Technologies a grant for a Program Project for which Marina E. Emborg designed the efficacy study in monkeys that was proposed to the Foundation. It was then directed by Marina E. Emborg. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","06","Sachiko Ohshima-Hosoyama","SOH",11,TRUE,1,8,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
